I. Statutes/regs on health care providers’ authority
to prescribe for STDs to a patient’s partner(s) w/out prior evaluation (Explanation) |
|
II. Specific judicial decisions concerning EPT (or like practices) (Explanation) |
|
III. Specific administrative opinions by the Attorney General
or medical or pharmacy boards concerning EPT (or like practices) (Explanation) |
|
IV. Legislative bills or prospective regulations concerning EPT
(or like practices) (Explanation) |
|
V. Laws that incorporate via reference guidelines as acceptable
practices (including EPT) (Explanation) |
|
VI. Prescription requirements (Explanation) |
Patient’s full name required on prescription label regarding
any prescription drug “for the use of a patient or other third party….” Del.
Code Ann. tit. 24 § 2536(b)(3) (noting that no third-party information
is required on the label).
Pursuant to a valid prescription, a pharmacist is allowed to dispense
a drug “for subsequent administration or use by a patient or other
individual entitled to receive the prescription.”
Del
Code Ann. tit. 24, Chapt. 25 § 2502(c)
|
VII. Assessment of EPT’s legal status with brief comments (Explanation) |
EPT is potentially allowable.
Statutory authority does not preclude EPT. Prescriptions may be issued
for the use of a third party other than the patient. Furthermore, partner
information is not required on the prescription label.
|
Status as of August 16, 2006 |